Saratoga Health & Biotechnology Portfolio Fund Class A (SHPAX)
| Fund Assets | 10.46M |
| Expense Ratio | 3.00% |
| Min. Investment | $250 |
| Turnover | 22.00% |
| Dividend (ttm) | 0.78 |
| Dividend Yield | 3.45% |
| Dividend Growth | 207.34% |
| Payout Frequency | Annual |
| Ex-Dividend Date | n/a |
| Previous Close | 21.25 |
| YTD Return | -0.94% |
| 1-Year Return | 15.64% |
| 5-Year Return | 27.62% |
| 52-Week Low | 18.18 |
| 52-Week High | 22.75 |
| Beta (5Y) | n/a |
| Holdings | 30 |
| Inception Date | Jul 15, 1999 |
About SHPAX
Saratoga Health & Biotechnology Portfolio Fund Class A is a mutual fund that primarily targets the health care and biotechnology sectors. The fund seeks long-term capital growth by investing at least 80% of its assets in equity securities of companies engaged in health care, pharmaceuticals, medical products, research, and biotechnology, both in the United States and internationally. Managed since 1999, it holds a diversified portfolio with approximately 32 holdings and notable concentrations in large-cap health care companies. Its top holdings include prominent industry names such as McKesson, Amgen, and Intuitive Surgical, reflecting a focus on market leaders within health innovation. The fund has an annual expense ratio of around 2.7% and requires a minimum initial investment of $250. With a strategy centered on growth in sectors driven by advances in medicine and technology, Saratoga Health & Biotechnology Portfolio Fund Class A plays a specialized role for investors seeking specific exposure to the evolving health and biotechnology industries.
Performance
SHPAX had a total return of 15.64% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.21%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
| Symbol | Provider | Name | Expense Ratio |
|---|---|---|---|
| FIKCX | Fidelity | Fidelity Advisor Health Care Fund - Class Z | 0.59% |
| FSPHX | Fidelity | Fidelity Select Health Care Portfolio | 0.62% |
| FIJYX | Fidelity | Fidelity Advisor Biotechnology Fund - Class Z | 0.61% |
| FACDX | Fidelity | Fidelity Advisor Health Care Fund - Class A | 0.98% |
| FSHCX | Fidelity | Fidelity Select Health Care Services Portfolio | 0.67% |
Top 10 Holdings
52.00% of assets| Name | Symbol | Weight |
|---|---|---|
| Cardinal Health, Inc. | CAH | 6.68% |
| United Therapeutics Corporation | UTHR | 6.34% |
| Amgen Inc. | AMGN | 5.69% |
| Jazz Pharmaceuticals plc | JAZZ | 5.65% |
| McKesson Corporation | MCK | 5.52% |
| Cencora, Inc. | COR | 4.88% |
| Regeneron Pharmaceuticals, Inc. | REGN | 4.77% |
| Novartis AG ADR | NVSN.MX | 4.42% |
| Johnson & Johnson | JNJ | 4.10% |
| Gilead Sciences, Inc. | GILD | 3.94% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 9, 2025 | $0.7788 | Dec 10, 2025 |
| Dec 10, 2024 | $0.2534 | Dec 11, 2024 |
| Dec 8, 2023 | $1.0202 | Dec 11, 2023 |
| Dec 9, 2022 | $1.2749 | Dec 12, 2022 |
| Dec 10, 2021 | $0.7883 | Dec 13, 2021 |
| Dec 11, 2020 | $2.5794 | Dec 11, 2020 |